Navigation Links
Cell Therapeutics Updates Shareholders on Trading
Date:2/11/2009

SEATTLE, Feb. 11 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (Nasdaq and MTA: CTIC) announced today that the Borsa Italiana, which is the entity that governs the trading of the Company's common stock on the MTA stock market in Milan, Italy, suddenly suspended trading of the Company's shares in Italy on February 10th. As a result of the suspension of trading by the Borsa Italiana, the security has additionally been halted on the NASDAQ Stock Market pursuant to Marketplace Rule 4120(a)(4) when a security is also registered on a foreign securities exchange and the foreign securities exchange halts trading in such security for regulatory reasons. We have not been advised of any independent basis for NASDAQ's decision to halt trading.

The Company's common stock has traded on the MTA since 2004 and is thus required to comply with the rules and regulations of the Commissione Nazionale per le Societe e la Borsa, or CONSOB, which is the public authority responsible for regulating the Italian securities markets and the Borsa Italiana, which oversees the trading market in Italy. Collectively these agencies regulate companies listed on Italy's public markets. The Company has responded to numerous requests by both the Borsa Italiana and CONSOB to provide additional clarifications about its business operations and financial condition, and the Company has met with CONSOB on several occasions, most recently on February 6th, to answer such questions. As in the past, the Company believes it has complied with CONSOB's requests to issue additional press releases in Italy and if required filed as Form 8-K in the US clarifying the information contained in the Company's SEC filings and press releases and the Company is committed to continuing to do so. The Company is waiting for clarification from the Borsa Italiana and CONSOB as to what additional information or action the Company must take, if any, for the Borsa Italiana to resum
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results
2. Arete Therapeutics Initiates Phase IIa Clinical Trial for AR9281, a Novel s-EH Inhibitor to Treat Type 2 Diabetes
3. Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2009 Financial Results on Wednesday, February 11th, at 4:30 P.M. EST
4. Transition Therapeutics Announces Completion of Patient Enrolment of Phase 2 Study of TT-223 in Type 2 Diabetes Patients
5. Nile Therapeutics to Present at the 2009 BIO CEO & Investor Conference
6. Nile Therapeutics to Present at the 27th Annual J.P. Morgan Healthcare Conference
7. Merck Serono and Apitope Announce Licensing Agreement on Novel Peptide Therapeutics for the Treatment of Multiple Sclerosis
8. AHRQ Announces New Web Site on Emerging Issues in Medical Therapeutics
9. Cell Therapeutics Receives $7.5 Million Under Joint Venture Agreement With Spectrum Pharmaceuticals
10. Orexigen(R) Therapeutics to Speak at J.P. Morgan Healthcare Conference
11. Prime Therapeutics Hires Steven Blumenfield as Chief Marketing Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... (PRWEB) May 23, 2013 With crowded ... more popular. But according to Mike Whitfield, a bodyweight ... of equipment like the medicine ball can add a ... Whitfield runs BodyweightTorch.com, a website in which anyone can ... uses no equipment. Recently, he shared a video with ...
(Date:5/23/2013)... Studies show that kids and teens who ... less likely to be overweight, less likely to engage in ... have better relationships with their parents. , Despite ... family dinner expert and advocate Aviva Goldfarb . Over ... percent. When families do eat together, average mealtimes last a ...
(Date:5/23/2013)... May 23, 2013 Dr. Garber's ... condition specific remedies are now available at Whole Foods ... CA 92677. The line of natural biotherapy formulas continues ... Chain. , Represented by Brandstorm HBC (Los Angeles, CA), ... Markets throughout California, Nevada and Arizona, as well as ...
(Date:5/23/2013)... Brad Schmett, Broker Associate with Luxury Homes ... Palm Springs area real estate market will ... of the Annual Memorial Day Flower Drop at the ... , Culminating the festive three-day weekend, Valley residents will ... with flight exhibitions. However, the highlight of the Memorial ...
(Date:5/23/2013)... 23, 2013 To help members ... Walkingspree is pleased to announce integration of its ... devices. This new upgrade automatically transfers real-time step ... to track their company’s team standings, view progress ... fat burned. , Walkingspree also offers an integrated ...
Breaking Medicine News(10 mins):Health News:Unique Ab Exercise, the Medicine Ball Chop, Released from BodyweightTorch.com 2Health News:Family Dinner Expert and Cookbook Author Announces “Family Dinner Challenge” 2Health News:Dr. Garber's Natural Solutions Now Available at Whole Foods Market, Laguna Niguel, CA 2Health News:Annual Memorial Day Flower Drop Honors Veterans in Palm Springs California by Brad Schmett 2Health News:Walkingspree Expands Device Options with Fitbit to Increase Member Engagement in Corporate Wellness Programs 2Health News:Walkingspree Expands Device Options with Fitbit to Increase Member Engagement in Corporate Wellness Programs 3
... special clinic on wheels is being launched for sex ... treatment for sexually transmitted// disease along with blood test ... mobile clinic that would provide blood test facilities, treatment ... of sex workers for free is being launched here ...
... Indonesia's Bogor Institute of Agriculture have announced a joint ... for animals. The company to be called IPB Shigeta ... vaccine in a very short time. ,U.S.-based ... company to use its patented reverse genetics technology to ...
... friendly 7-year-old at Shaughnessy Elementary School died on Tuesday due ... had fever and headache and was sent home by the ... up and she did not budge she was taken to ... pronounced dead. She is the first child under 12 to ...
... even after eight days//. Now resident doctors from hospitals have ... in the city. ,Resident doctors in lab coats, ... to appeal to the public. Doctors from JJ hospital, KEM ... Mumbaikars on their way to work. ,The Doctor ...
... Hospitals trust is going to cut off nearly 300 jobs ... funding formula that incurred huge losses. //Royal Cornwall Hospitals Trust ... debts of ?8.1 million which might force it to ... ,Market Forces Factor (MFF) has perhaps caused this downslide, ...
... Institute for Health Information (CIHI) said that despite the ... been no shortening of waiting time. // Glenda Yeates, ... of diagnostic tests and high-priority procedures has increased dramatically. ... increased just as much. Statistics show that the number ...
Cached Medicine News:Health News:Mobile Clinic For Sex Workers In Pune 2
(Date:5/23/2013)... and DRESDEN, Germany , ... BioScience, a leading preclinical contract research provider and ... content-driven pharmacology, and Debiopharm Group™ (Debiopharm), a Swiss-based ... on the development of prescription drugs that target ... today announced that they have signed a research ...
(Date:5/22/2013)... 22, 2013  Aribex, Inc., manufacturer of the newly ... a new color option, black with gray trim, of ... veterinary markets. The popular white with light blue trim ... to be available and both models can be purchased ... (Photo: http://photos.prnewswire.com/prnh/20130522/CL19573 ) "Dental offices are ...
(Date:5/22/2013)... 22, 2013 Advanced Prenatal Therapeutics (APT), a ... will help alleviate the high blood pressure and other ... expected to be the first medical device specifically designed ... fetal death. Every year, preeclampsia affects approximately ... . It is characterized by high blood pressure ...
Breaking Medicine Technology:Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 2Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 3Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 4Aribex Unveils New Color of NOMAD Pro 2 2Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia 2
... March 2, 2011 InspireMD ... system , has expanded its MGuard production facilities to ... behind the accelerating demand for MGuard include the recent ... protection to be considered for PCI of highly thrombotic ...
... 2011 Accumetrics, Inc., a privately-held developer and marketer ... point-of-care diagnostic system for measuring platelet reactivity to multiple ... an agreement with Portola Pharmaceuticals, Inc. to develop and ... clinical trials. The VerifyNow System is widely ...
Cached Medicine Technology:InspireMD Boosts MGuard Production Capacity 2Accumetrics Signs Development & Supply Agreement With Portola Pharmaceuticals, Inc. 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: